TB90
WHAT IS IT?
TB90 is a testosterone boosting supplement designed to increase endogenous testosterone levels while minimizing estrogenic side effects. TB90 also provides crucial supporting ingredients for heart health and liver health.
WHY WOULD I TAKE IT?
If you’re looking to increase lean muscle tissue, enhance libido, or just want to facilitate more fat loss.
HOW DOES THIS WORK?
TB90 focuses on 4 main principles: 1) To increase testosterone 2) Minimizing estrogenic side effects 3) Keeping the liver healthy 4) Improving overall blood flow. The first principle is based off of a combination of two ingredients: D-Aspartic Acid, which allows for activation of NMDA receptors in the brain to increase testosterone production in the testes, and DHEA which acts as a testosterone precursor to act as a “fuel” for testosterone production. Minimizing estrogenic side effects is accomplished not by completely diminishing all estrogenic activity but by decreasing the potency of estrogenic metabolites. N-Acetyl-L-Cysteine and Milk Thistle then act as antioxidants and hepatoprotectants to ensure proper detoxification, while Hawthorn Berry and Grape seed extract work to improve overall blood flow and circulation.
HOW MUCH SHOULD I TAKE?
We suggest taking three capsules daily. These three capsules are best taken either first-thing in the morning, or 45-60 minutes prior to exercise.
TOP 5 STUDIES:
1 - D-Aspartic acid: An endogenous amino acid with an important neuroendocrine role.
https://www.sciencedirect.com/science/article/pii/S0165017306001020
2 - DHEA in Elderly Women and DHEA or Testosterone in Elderly Men.
https://www.nejm.org/doi/full/10.1056/NEJMoa054629
3 - Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
https://academic.oup.com/carcin/article/19/9/1631/2365563
4 - Hawthorn: Pharmacology and therapeutic uses.
https://academic.oup.com/ajhp/article-abstract/59/5/417/5157981
5 - Milk thistle in liver diseases: past, present, future.
https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.3207
